LSE - Delayed Quote USD

Aflac Incorporated (0H68.L)

Compare
109.75
-2.21
(-1.97%)
At close: 5:49:10 PM GMT+1
Loading Chart for 0H68.L
  • Previous Close 111.96
  • Open 108.73
  • Bid --
  • Ask --
  • Day's Range 103.99 - 110.08
  • 52 Week Range 60.54 - 110.08
  • Volume 1,031
  • Avg. Volume 9,591
  • Market Cap (intraday) 80.83B
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 0.18
  • EPS (TTM) 6.09
  • Earnings Date Apr 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aflac Incorporated, through its subsidiaries, engages in the provision of supplemental health and life insurance products. The company operates in two segments: Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The AFLAC U.S. offers accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

www.aflac.com

12,694

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0H68.L

View More

Performance Overview: 0H68.L

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0H68.L
6.78%
MSCI WORLD (^990100-USD-STRD)
9.47%

1-Year Return

0H68.L
31.68%
MSCI WORLD (^990100-USD-STRD)
0.88%

3-Year Return

0H68.L
81.00%
MSCI WORLD (^990100-USD-STRD)
8.93%

5-Year Return

0H68.L
278.47%
MSCI WORLD (^990100-USD-STRD)
88.90%

Compare To: 0H68.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0H68.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.76%

  • Return on Assets (ttm)

    3.38%

  • Return on Equity (ttm)

    22.64%

  • Revenue (ttm)

    18.93B

  • Net Income Avi to Common (ttm)

    5.44B

  • Diluted EPS (ttm)

    6.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.83B

  • Total Debt/Equity (mrq)

    37.80%

  • Levered Free Cash Flow (ttm)

    4.85B

Research Analysis: 0H68.L

View More

Company Insights: 0H68.L

Research Reports: 0H68.L

View More

People Also Watch